Antabuse: Clinically Proven Alcohol Deterrent Therapy
| Product dosage: 250mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 90 | $0.51 | $46.18 (0%) | 🛒 Add to cart |
| 120 | $0.48 | $61.58 $57.23 (7%) | 🛒 Add to cart |
| 180 | $0.46 | $92.37 $82.33 (11%) | 🛒 Add to cart |
| 270 | $0.44 | $138.55 $118.47 (14%) | 🛒 Add to cart |
| 360 | $0.43
Best per pill | $184.74 $153.61 (17%) | 🛒 Add to cart |
| Product dosage: 500mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.95 | $57.23 (0%) | 🛒 Add to cart |
| 90 | $0.85 | $85.84 $76.30 (11%) | 🛒 Add to cart |
| 120 | $0.79 | $114.46 $94.38 (18%) | 🛒 Add to cart |
| 180 | $0.73 | $171.68 $130.52 (24%) | 🛒 Add to cart |
| 270 | $0.69 | $257.53 $185.74 (28%) | 🛒 Add to cart |
| 360 | $0.67
Best per pill | $343.37 $242.97 (29%) | 🛒 Add to cart |
Synonyms | |||
Antabuse (disulfiram) is a prescription medication designed to support the treatment of chronic alcoholism by creating a physiological deterrent to alcohol consumption. It functions as an aversive therapy, inducing an unpleasant reaction when alcohol is ingested, thereby helping patients maintain abstinence as part of a comprehensive management plan that includes counseling and psychosocial support. This agent is indicated for use in motivated individuals under medical supervision, serving as an adjunct to broader therapeutic strategies aimed at achieving long-term sobriety.
Features
- Contains disulfiram as the active pharmaceutical ingredient
- Available in 250 mg and 500 mg oral tablets
- Inhibits the enzyme aldehyde dehydrogenase
- Requires a prescription and professional medical oversight
- Compatible with integrated treatment programs including behavioral therapy
Benefits
- Provides a strong physiological deterrent to alcohol consumption
- Supports patient commitment to sobriety through aversive conditioning
- Integrates seamlessly with multidisciplinary addiction treatment plans
- Helps break the cycle of alcohol dependency by creating immediate negative feedback
- May reduce cravings through psychological reinforcement of abstinence
- Facilitates long-term behavioral modification when used as directed
Common use
Antabuse is primarily prescribed as part of a comprehensive treatment program for alcohol dependence in motivated patients who desire to maintain a state of enforced sobriety. It is typically initiated after the patient has undergone alcohol detoxification and has remained abstinent for at least 12 hours. The medication is used as an aversive conditioning tool, where the threat of the disulfiram-ethanol reaction helps patients resist alcohol consumption during critical periods of treatment. Healthcare providers often recommend Antabuse for patients who have previously relapsed despite other interventions, or for those who specifically request pharmacological support for maintaining abstinence.
Dosage and direction
The initial dosage is typically 500 mg daily for 1-2 weeks, administered as a single dose in the morning. Maintenance dosage is usually 250 mg daily (range 125-500 mg), though dosage should be individualized based on patient response and tolerance. The tablet should be swallowed whole with water and may be taken with food to minimize gastrointestinal discomfort. Treatment should not be initiated until the patient has abstained from alcohol for at least 12 hours and preferably longer. The duration of treatment is individualized and may continue for months or even years, depending on the patient’s progress in recovery.
Patients must be fully informed about the consequences of alcohol consumption while taking Antabuse and must provide explicit consent before initiation. Regular follow-up appointments are essential to monitor compliance, assess effectiveness, and manage any side effects.
Precautions
Patients must be thoroughly educated about the disulfiram-ethanol reaction and must completely avoid all forms of alcohol, including medications, foods, and toiletries containing alcohol. Even small amounts of alcohol can trigger a reaction, which may occur up to 14 days after the last dose of Antabuse. Regular liver function tests are recommended during therapy due to potential hepatotoxicity. Use with caution in patients with diabetes mellitus, hypothyroidism, epilepsy, cerebral damage, chronic or acute nephritis, or hepatic impairment. Patients should carry identification indicating they are taking disulfiram.
Healthcare providers should monitor for signs of psychosis, depression, or suicidal ideation, as these may occur in patients with alcohol dependence regardless of treatment. Patients should be advised that the disulfiram-ethanol reaction may occur with exposure to alcohol vapors or topical alcohol-containing products.
Contraindications
Antabuse is contraindicated in patients with severe myocardial disease or coronary occlusion, as the disulfiram-ethanol reaction may cause cardiovascular complications. It should not be used in patients with psychosis or those who have exhibited hypersensitivity to disulfiram or other thiuram derivatives. Contraindicated in patients receiving alcohol-containing preparations or metronidazole, paraldehyde, or certain other medications that may interact adversely. Not recommended for use during pregnancy unless clearly needed and potential benefits justify potential risks to the fetus. Should not be administered without the patient’s knowledge or consent.
Possible side effects
Common side effects include drowsiness, fatigue, headache, metallic or garlic-like aftertaste, and skin eruptions. These typically diminish with continued therapy. Less frequently reported effects include impotence, optic neuritis, peripheral neuropathy, and hepatic toxicity. The most significant adverse effect is the disulfiram-ethanol reaction, characterized by flushing, throbbing in head and neck, throbbing headache, respiratory difficulty, nausea, copious vomiting, sweating, thirst, chest pain, palpitations, tachycardia, hypotension, syncope, marked uneasiness, weakness, vertigo, blurred vision, and confusion. In severe cases, respiratory depression, cardiovascular collapse, arrhythmias, myocardial infarction, acute congestive heart failure, unconsciousness, convulsions, and death may occur.
Drug interaction
Antabuse may prolong the effects of benzodiazepines, barbiturates, and other CNS depressants. It inhibits the metabolism of phenytoin, warfarin, and other drugs metabolized by hepatic microsomal enzymes, potentially increasing their serum levels and toxicity. Concurrent use with isoniazid may cause coordination difficulties or changes in mental status. Metronidazole should not be administered with disulfiram due to increased risk of psychotic reactions. May increase blood levels of theophylline, potentially leading to toxicity. Alcohol-containing medications, including some cough syrups, tonics, and elixirs, may precipitate a disulfiram-ethanol reaction.
Missed dose
If a dose is missed, it should be taken as soon as remembered unless it is almost time for the next dose. Patients should not double the dose to make up for a missed one. Consistency in dosing is important for maintaining the aversive effect, but occasional missed doses are less critical than maintaining the treatment regimen overall. Patients should contact their healthcare provider if multiple doses are missed or if they have questions about resuming therapy.
Overdose
Symptoms of overdose may include nausea, vomiting, dizziness, ataxia, and in severe cases, seizures, respiratory depression, or cardiovascular collapse. Management is primarily supportive, with gastric lavage considered if presentation is early. There is no specific antidote. Hemodialysis may be considered in severe cases. Treatment should focus on maintaining vital functions and managing symptoms. Patients suspected of overdose should receive immediate medical attention.
Storage
Store at controlled room temperature between 20°C to 25°C (68°F to 77°F). Keep in the original container, tightly closed, and protect from light and moisture. Keep out of reach of children and pets. Do not use after the expiration date printed on the packaging. Proper disposal of unused medication is important to prevent accidental ingestion.
Disclaimer
This information is for educational purposes only and does not constitute medical advice. Antabuse is a prescription medication that should only be used under the supervision of a qualified healthcare professional. Patients must consult their physician before starting, stopping, or changing any medication regimen. Individual responses to medication may vary, and only a healthcare provider can determine the appropriate treatment based on a patient’s specific medical condition and history.
Reviews
Clinical studies have demonstrated Antabuse’s efficacy in supporting alcohol abstinence when used as part of a comprehensive treatment program. Research indicates that motivated patients who comply with therapy show significantly improved abstinence rates compared to those receiving placebo. Many addiction specialists report that Antabuse provides valuable psychological reinforcement for patients committed to recovery, particularly during early stages of treatment when relapse risk is highest. Patient experiences vary, with some reporting excellent results when used as directed, while others note side effects that limited continued use. Success appears highest when combined with counseling and support groups.
Long-term follow-up studies suggest that patients who complete at least six months of Antabuse therapy combined with psychosocial support maintain higher rates of sustained abstinence compared to those receiving psychosocial support alone. The medication is generally well-tolerated when prescribed appropriately and monitored regularly.